BlackRock Health Sciences Term Trust (NYSE:BMEZ) Major Shareholder Saba Capital Management, L.P. Acquires 8,012 Shares

BlackRock Health Sciences Term Trust (NYSE:BMEZ) major shareholder Saba Capital Management, L.P. acquired 8,012 shares of the business’s stock in a transaction dated Monday, September 30th. The shares were acquired at an average price of 15.84 per share, for a total transaction of 126,910.08. Following the acquisition, the insider now directly owns 20,661,390 shares in the company, valued at 327,276,417.60. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

• On Friday, September 27th, Saba Capital Management, L.P. bought 1,633 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average cost of 15.89 per share, for a total transaction of 25,948.37.
• On Wednesday, September 25th, Saba Capital Management, L.P. bought 300 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average price of 15.73 per share, with a total value of 4,719.00.
• On Monday, September 23rd, Saba Capital Management, L.P. bought 2,006 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average price of 15.98 per share, with a total value of 32,055.88.
• On Thursday, September 19th, Saba Capital Management, L.P. bought 15,455 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average price of 16.14 per share, with a total value of 249,443.70.
• On Tuesday, September 17th, Saba Capital Management, L.P. bought 27,148 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average cost of 15.93 per share, for a total transaction of 432,467.64.

BlackRock Health Sciences Term Trust Stock Down 0.2 %

BMEZ stock traded down 0.03 during midday trading on Tuesday, hitting 15.81. The company’s stock had a trading volume of 100,465 shares, compared to its average volume of 274,754. BlackRock Health Sciences Term Trust has a 1 year low of 12.93 and a 1 year high of 16.59. The stock’s 50-day moving average price is 15.85 and its 200 day moving average price is 15.53.

BlackRock Health Sciences Term Trust Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Thursday, October 31st. Shareholders of record on Tuesday, October 15th will be paid a $0.176 dividend. The ex-dividend date of this dividend is Tuesday, October 15th. This represents a $2.11 dividend on an annualized basis and a yield of 13.36%.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

A number of hedge funds and other institutional investors have recently modified their holdings of BMEZ. Sessa Capital IM L.P. increased its position in BlackRock Health Sciences Term Trust by 27.1% during the 2nd quarter. Sessa Capital IM L.P. now owns 1,853,022 shares of the company’s stock valued at $28,462,000 after buying an additional 395,288 shares in the last quarter. Almitas Capital LLC raised its holdings in BlackRock Health Sciences Term Trust by 89.3% during the second quarter. Almitas Capital LLC now owns 1,761,943 shares of the company’s stock valued at $27,063,000 after acquiring an additional 831,025 shares during the period. Karpus Management Inc. raised its holdings in BlackRock Health Sciences Term Trust by 14.9% during the first quarter. Karpus Management Inc. now owns 1,398,681 shares of the company’s stock valued at $22,924,000 after acquiring an additional 181,092 shares during the period. Lazard Asset Management LLC raised its holdings in BlackRock Health Sciences Term Trust by 24.3% during the first quarter. Lazard Asset Management LLC now owns 798,962 shares of the company’s stock valued at $13,094,000 after acquiring an additional 156,417 shares during the period. Finally, Allspring Global Investments Holdings LLC increased its holdings in shares of BlackRock Health Sciences Term Trust by 66.3% in the second quarter. Allspring Global Investments Holdings LLC now owns 399,964 shares of the company’s stock worth $6,143,000 after purchasing an additional 159,401 shares during the last quarter.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.